Literature DB >> 1908231

The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups.

K Yoshioka1, T Miki, T Katsuya, T Ogihara, Y Sakaki.   

Abstract

Alzheimer's disease (AD) is a devastating neurological disorder and the leading cause of dementia among aged individuals. The human amyloid beta protein, which is a cleavage product of amyloid precursor protein (APP), is a major component of the amyloid deposited in the brain of patients with AD. By using PCR direct sequencing of exon 17 (encoding part of the beta protein) of the APP gene, we have found that a Japanese AD patient harbours a C to T substitution, responsible for a valine to isoleucine change at position 717, heterogeneously. The mutation is exactly the same as that found in a Caucasian AD family by Goate et al. (1). Furthermore, the mutation was shown to co-segregate with AD in his family. These results suggest that the Val----Ile change in the APP causes AD, regardless of ethnic background.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908231     DOI: 10.1016/0006-291x(91)91011-z

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases.

Authors:  R E Tanzi; G Vaula; D M Romano; M Mortilla; T L Huang; R G Tupler; W Wasco; B T Hyman; J L Haines; B J Jenkins
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 2.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

Review 3.  The role of beta-amyloid in the development of Alzheimer's disease.

Authors:  K Ii
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

4.  A physical map of the human APP gene in YACs.

Authors:  K Rooke; C Talbot; L James; R Anand; J A Hardy; A M Goate
Journal:  Mamm Genome       Date:  1993-11       Impact factor: 2.957

5.  Mutational analysis of the amyloid precursor protein gene in Japanese familial Alzheimer's disease kindreds.

Authors:  H Fujigasaki; S Naruse; K Kaneko; H Hirasawa; S Tsuji; T Miyatake
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

Review 6.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

7.  RFLP analysis for APP 717 mutations associated with Alzheimer's disease.

Authors:  S R Zeldenrust; J Murrell; M Farlow; B Ghetti; A D Roses; M D Benson
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

Review 8.  Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.

Authors:  A J Rozemuller; R A Roos; G T Bots; W Kamphorst; P Eikelenboom; W E Van Nostrand
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.

Authors:  S Tanaka; Y Toh; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 10.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.